e-Drug3D 519 |
cas 13311-84-7 |
CLASS ANTINEOPLASTIC |
ROUTE (list) ORAL |
ATC code |
PK parameters F 100 PERCENT |
Target TARGET ANDROGEN RECEPTOR |
DrugCentral Androgen receptor UNIPROT P10275 AR |
Download SDF file | 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide Formula: Calculated chemical properties: MW 276.22 NB_atoms 19 XLogP 0 PSA 62.758 NB_HD 1 NB_HA 4 fsp3 0.36 Lipinski(0=no;1=yes) 1 |
FDA NDA 018554 (pdf not found) INN (FLUTAMIDE) EULEXIN (SCHERING) APPROVAL= AP YEAR= 1989 DISCONTINUED NDA 075298 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (WAYLIS THERAP) APPROVAL= AP YEAR= 2001 NDA 075780 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (CIPLA) APPROVAL= AP YEAR= 2001 DISCONTINUED NDA 075818 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2001 DISCONTINUED NDA 075820 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2001 DISCONTINUED NDA 076224 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2003 DISCONTINUED |
Other links: |